Cell-culture studies report molecular changes over hours to days
Biomechanically, the healed tendons (over 14 days) showed an increased load to tendon failure and significantly higher functionality (Achilles functional IndexAFI)
Used to treat B vitamin deficiency, support nerve health, relieve neurological pain, and combat deficiency-related fatigue
Phase I Safety Trial: As noted, a Phase I trial (the first step in testing a drug in humans, usually focused on safety and pharmacokinetics) was registered in 2015, aiming to give BPC-157 to healthy volunteers
Unlike traditional medications, peptides like BPC-157 work by signaling and enhancing the bodys internal repair mechanisms, making them a valuable complement to treatments such as stem cell therapy and umbilical cord stem cells